Salix Nigra Bark Extract

Salix Nigra (black willow) bark extract is commonly used as a “natural salicylic” exfoliating/anti-acne active; depending on standardization it can deliver salicylates and other phenolics at leave-on concentrations that meaningfully increase stinging and barrier disruption risk. Patch-test and clinical experience show botanical extracts can provoke irritant reactions and occasional allergy, and salicylate-containing extracts are more problematic in eczema-prone or compromised skin and when layered with other exfoliants/retinoids. Given its active-like keratolytic intent, variable composition, and higher risk in sensitive populations, it warrants careful introduction. Safety Notes: In mass-market and prestige cleansers/toners/lotions, Salix Nigra (willow) bark extract is frequently used as a low-level botanical supporting ingredient around 0.01–0.5% (often within multi-extract blends), especially in leave-on products where the extract is not the primary active. Higher-strength OTC “natural BHA/clarifying” serums, masks, and spot treatments marketed around willow bark can reach ~1–5% extract, with a small number of consumer-available formulas listing willow bark extract at very high levels up to about 10% (typically depending on supplier standardization and solvent system). There is no specific EU/FDA maximum for this botanical itself; practical limits are driven by extract composition, salicylate content/claims positioning, color/odor, and irritation risk, with rinse-off products generally tolerating the upper end more readily than leave-on.